Optimal design and endpoint of clinical trials using immune checkpoint blocking agents
- PMID: 27740862
- DOI: 10.1080/14737140.2016.1248945
Optimal design and endpoint of clinical trials using immune checkpoint blocking agents
Keywords: Immune checkpoint blocking agents; PD-1; PD-L1; clinical trial design; endpoint.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials